Welcome to Reproductive Medicine Network funded by NICHD
The Reproductive Medicine Network (RMN), established in 1989 and funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), is a cooperative effort of seven clinical sites, a data coordinating center, and the Reproductive Science Branch of the NICHD, charged with conducting and publishing high quality clinical studies in reproductive medicine.
- NIH Press Release: RMN finds PCOS women treated with progestin four times less likely to conceive. The finding is believed to have major implications for practice. Please refer to Progestin treatment for polycystic ovarian syndrome may reduce pregnancy chances for details.
- Infertility Clinical Trials: PPCOS II enrollment completed in January 2012, AMIGOS in September 2012, and PhOx in April 2013. More.
- Publications: RMN has published numerous manuscripts on infertility findings and issues. More.
Collaborations: The RMN has collaborative initiatives both nationally and internationally:
- RMN PIs mentor NIH-funded CREST Scholars on recruitment for and implementation of RMN trials, enabling them to actualize their research training. Mentorships include various ancillary studies and grant proposals which are projected to evolve into published manuscripts.
- RMN collaborates on ancillary studies with funded researchers by sharing specimens and data.
- RMN subcommittees collaborate on prospective projects with SCCPIR Focus Groups.
- RMN PIs are expanding the impact of the Network by collaborating with Chinese colleagues on the development and implementation of infertility protocols in China.
A news story on KENS5 aired in Texas about the AMIGOS study, featuring one of our clinical sites at University of Texas, Health Center at San Antonio. You can also watch the
video and read the news article about this story on www.kens5.com.
For more videos about RMN studies, please click here or the "Media" link on the left navigation panel.